Cite Filings / ABOS
Feed Companies Filings Check
Sign in

CIK 0001576885 · <br>Emerging growth company

Acumen Pharmaceuticals, Inc.

Sign in to watch
Ticker
ABOS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364108129
Phone
617-344-4190
Business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
Filings Insiders Search text
All 365 Financials 79 Shareholder Meetings 6 Executive Compensation 67 Insider Trading 140 Beneficial Ownership Interest 26 Business Combinations 57 Public Offerings 26 Mutual Funds and ETFs 5 Others 93
›
Filed in
  1. No filings match these filters. Clear filters
  2. DRSLTR Other Correspondence Related to Draft Registration Statement 2021-05-14
  3. DRS/A Other Draft Registration Statement 2021-05-14
  4. UPLOAD Other SEC-generated Letter 2021-05-10
  5. DRS Other Draft Registration Statement 2021-04-12
  6. D Other Notice of Sales of Unregistered Securities 2013-05-15

Page 19 of 19 · 365 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…